CGABL earnings: real EPS beat/miss history, P/E 28.95. Updated 2026-07-23.
The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (CGABL) Research Hub
The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (CGABL) trades on NASDAQ, US in the Financial Services (Financial - Credit Services) sector. As of 2026-09-11, shares last closed at 15.89 USD (+0.38%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 28.95, market cap 5.88B. This hub links to the full technical, earnings and options research available for CGABL.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Financial Services (Financial - Credit Services) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 15.89 USD (+0.38%) |
| 52-week range | 15.71 USD – 16.64 USD |
| Trend regime | Range |
| 14-day RSI | 43.7 (Bearish) |
| Trailing P/E | 28.95 |
| Market cap | 5.88B |
| Dividend yield | 3.18% |
Available research for CGABL
Covered Call on CGABL: how it works, illustrative setup around the real 15.89 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CGABL: how it works, illustrative setup around the real 15.89 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CGABL: how it works, illustrative setup around the real 15.89 USD price, max profit/loss, breakeven and when to use it. Educational.
CGABL technical analysis: range, last 15.89 USD, RSI 43.7, 52w range 15.71 USD–16.64 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is CGABL in?
The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (CGABL) is classified under Financial Services (Financial - Credit Services), listed on NASDAQ, US.
Is CGABL in an uptrend or downtrend?
As of 2026-09-11, CGABL is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CGABL's trailing P/E ratio?
CGABL's trailing P/E is 28.95, with a market cap of 5.88B. See the earnings research page for full valuation detail.